Back to search

United States· US:0615-8519_86d3c997-3449-46f4-8bc9-1805c5255e04

Prazosin Hydrochloride

A prazosin product containing prazosin hydrochloride, registered in United States by NCS HealthCare of KY, LLC dba Vangard Labs. The same ATC class is registered in 9 of our 19 countries.

In shortageATC C02CA01Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPrazosin HydrochlorideATCC02CA01REGISTER NO.US:0615-8519_86d3c997…PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Prazosin is registered in 9 of 19 countries.

Countries holding a registration under ATC C02CA01 (prazosin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Prazosin · ATC C02CA01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Prazosin Hydrochloride
Manufacturer
NCS HealthCare of KY, LLC dba Vangard Labs
Country
United States (US)
ATC code
C02CA01
ATC class
Prazosin
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    0615851939
    30 CAPSULE in 1 BLISTER PACK (0615-8519-39)

Regulatory notes

UNII (FDA substance ID)
X0Z7454B90
PRAZOSIN HYDROCHLORIDE
RxCUI 203210
Orange Book
A210971
ABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Prazosin Hydrochloride Capsule

Interactions

98 interactions on record for prazosin.

Graded by severity as the source publishes them — 78 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Prazosin · interactions on record

98 records

  • 78 moderate
  • 20 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Prazosin in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prazosin products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Cyprus · Atodel
  • Spain · Minipres
  • Finland · Pratsiol
  • France · Alpress L.P.
  • United Kingdom (Northern Ireland) · Hypovase
  • Ireland · Hypovase

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9f8ab45-97bd-47a0-89f2-7db6ea3013cd
GET /v1/drugs/e9f8ab45-97bd-47a0-89f2-7db6ea3013cd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "X0Z7454B90",
    "rxcui": "203210",
    "inchikey": "WFXFYZULCQKPIP-UHFFFAOYSA-N",
    "display_name": "PRAZOSIN HYDROCHLORIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "52ce82b0-3cb5-b5b2-e063-6394a90a9f12": {
      "match": "brand_token",
      "title": "PRAZOSIN HYDROCHLORIDE CAPSULE [COUPLER LLC]",
      "spl_version": "1",
      "published_date": "2026-05-28"
    }
  },
  "productid": "0615-8519_86d3c997-3449-46f4-8bc9-1805c5255e04",
  "productndc": "0615-8519",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "210971",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 1MG BASE",
        "product_no": "001",
        "approval_date": "Oct 3, 2018"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 2MG BASE",
        "product_no": "002",
        "approval_date": "Oct 3, 2018"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 5MG BASE",
        "product_no": "003",
        "approval_date": "Oct 3, 2018"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "PRAZOSIN HYDROCHLORIDE",
  "shortage_reason": "Prazosin Hydrochloride Capsule",
  "shortage_status": "current",
  "proprietary_name": "Prazosin Hydrochloride",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA210971",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Prazosin Hydrochloride",
  "start_marketing_date": "20181003",
  "active_numerator_strength": "1"
}

See everything about prazosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.